Richard Hoffman
Net worth: 1 M $ as of 30/06/2026
Net worth: 1 M $ as of 30/06/2026
Richard A. Hoffman was the founder of TargetRx, Inc., founded in 1999, where the title held was Chief Executive Officer.
Mr. Hoffman currently works at Incyte Corp.
as Secretary, Executive VP & General Counsel since 2025.
Former jobs include Chief Executive Officer at Synglyco, Inc., Chief Business Officer at Ablexis LLC, and Partner at Goodwin Procter LLP.
Education history includes graduate degrees from The Trustees of Columbia University in The City of New York and Columbia Law School, an MBA from The Wharton School of the University of Pennsylvania, and an undergraduate degree from Harvard College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/12/2025 | 9,466 ( 0% ) | 1 M $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| INCYTE CORPORATION | General Counsel | 01/12/2025 |
| Companies | Position | End |
|---|---|---|
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
Ablexis LLC
Ablexis LLC Packaged SoftwareTechnology Services Develops next-generation platform for antibody drug discovery | Corporate Officer/Principal | - |
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Chief Executive Officer | - |
TargetRx, Inc.
TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing consultancy services | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
TargetRx, Inc.
TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing consultancy services | Commercial Services |
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Ablexis LLC
Ablexis LLC Packaged SoftwareTechnology Services Develops next-generation platform for antibody drug discovery | Technology Services |
Columbia Law School
Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions